Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julie R Ingelfinger

Showing results (21-30 of 239) with videos related to

Pageof 24
Sort By:
Journal of the American Society of Nephrology : JASN|October 6, 2006
ACE2: a new target for prevention of diabetic nephropathy?Julie R Ingelfinger
Pediatric Clinics of North America|October 10, 2006
The molecular basis of pediatric hypertensionJulie R Ingelfinger
Clinical Journal of the American Society of Nephrology : CJASN|June 27, 2020
Considering Our Patients and Tempering TerminologyJulie R Ingelfinger
The New England Journal of Medicine|October 25, 2024
Way Stations in Progress - Burgeoning Treatment Options for IgA NephropathyJulie R Ingelfinger
The New England Journal of Medicine|September 8, 2010
Hypertension control in African-American patients with chronic kidney diseaseJulie R Ingelfinger
The New England Journal of Medicine|November 7, 2017
Tolvaptan and Autosomal Dominant Polycystic Kidney DiseaseJulie R Ingelfinger
Clinical Journal of the American Society of Nephrology : CJASN|August 19, 2007
Through the looking glass: anemia guidelines, vested interests, and distortionsJulie R Ingelfinger
The New England Journal of Medicine|February 11, 2005
Agonistic autoantibodies and rejection of renal allograftsJulie R Ingelfinger
The New England Journal of Medicine|November 22, 2014
A new era for the treatment of hyperkalemia?Julie R Ingelfinger
The New England Journal of Medicine|July 19, 2018
A Remembrance of Life before Roe v. WadeJulie R Ingelfinger
Pageof 24

Showing results (21-30 of 239) with videos related to

Sort By:
Pageof 24
Journal of the American Society of Nephrology : JASN|October 6, 2006
ACE2: a new target for prevention of diabetic nephropathy?Julie R Ingelfinger
Pediatric Clinics of North America|October 10, 2006
The molecular basis of pediatric hypertensionJulie R Ingelfinger
Clinical Journal of the American Society of Nephrology : CJASN|June 27, 2020
Considering Our Patients and Tempering TerminologyJulie R Ingelfinger
The New England Journal of Medicine|October 25, 2024
Way Stations in Progress - Burgeoning Treatment Options for IgA NephropathyJulie R Ingelfinger
The New England Journal of Medicine|September 8, 2010
Hypertension control in African-American patients with chronic kidney diseaseJulie R Ingelfinger
The New England Journal of Medicine|November 7, 2017
Tolvaptan and Autosomal Dominant Polycystic Kidney DiseaseJulie R Ingelfinger
Clinical Journal of the American Society of Nephrology : CJASN|August 19, 2007
Through the looking glass: anemia guidelines, vested interests, and distortionsJulie R Ingelfinger
The New England Journal of Medicine|February 11, 2005
Agonistic autoantibodies and rejection of renal allograftsJulie R Ingelfinger
The New England Journal of Medicine|November 22, 2014
A new era for the treatment of hyperkalemia?Julie R Ingelfinger
The New England Journal of Medicine|July 19, 2018
A Remembrance of Life before Roe v. WadeJulie R Ingelfinger
Pageof 24